Abstract
Due to the bottlenecks encountered in traditional treatment for tumor, more effective drug targets need to be developed. Cell division cycle 7 kinase plays an important role in DNA replication, DNA repair and recombination signaling pathways. In this review, we first describe recent studies on the role of CDC7 in DNA replication in normal human tissues, and then we integrate new evidence focusing on the important role of CDC7 in replication stress tolerance of tumor cells and its impact on the prognosis of clinical oncology patients. Finally, we comb through the CDC7 inhibitors identified in recent studies as a reference for further research in clinical practice.
Funding Information
  • the National Nature Science Foundation of China (No. 82072340)
  • Scientific and Technological Innovation Major Base of Guangxi (2018-15-Z04)
  • State Project for Essential Drug Research and Development (2019ZX09301132)
  • Guangxi Key Research and Development Project (AB20117001)

This publication has 69 references indexed in Scilit: